Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
3.96 EUR
5.53 B EUR
42.51 B EUR
1.47 B
About ASTRAZENECA PLC ORD USD0.25
Sector
CEO
Pascal Soriot
Headquarters
Cambridge
Website
Founded
1992
ISIN
GB0009895292
FIGI
BBG000C8DGT7
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where ZEG is featured.
Frequently Asked Questions
The current price of ZEG is 120.10 EUR — it has decreased by −2.06% in the past 24 hours. Watch AstraZeneca PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange AstraZeneca PLC stocks are traded under the ticker ZEG.
ZEG stock has risen by 1.97% compared to the previous week, the month change is a −14.63% fall, over the last year AstraZeneca PLC has showed a 3.22% increase.
We've gathered analysts' opinions on AstraZeneca PLC future price: according to them, ZEG price has a max estimate of 218.19 EUR and a min estimate of 127.28 EUR. Watch ZEG chart and read a more detailed AstraZeneca PLC stock forecast: see what analysts think of AstraZeneca PLC and suggest that you do with its stocks.
ZEG stock is 3.21% volatile and has beta coefficient of 1.23. Track AstraZeneca PLC stock price on the chart and check out the list of the most volatile stocks — is AstraZeneca PLC there?
Today AstraZeneca PLC has the market capitalization of 191.92 B, it has increased by 0.66% over the last week.
Yes, you can track AstraZeneca PLC financials in yearly and quarterly reports right on TradingView.
AstraZeneca PLC is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
ZEG earnings for the last quarter are 1.87 EUR per share, whereas the estimation was 1.83 EUR resulting in a 1.83% surprise. The estimated earnings for the next quarter are 1.99 EUR per share. See more details about AstraZeneca PLC earnings.
AstraZeneca PLC revenue for the last quarter amounts to 12.18 B EUR, despite the estimated figure of 11.74 B EUR. In the next quarter, revenue is expected to reach 13.26 B EUR.
ZEG net income for the last quarter is 1.32 B EUR, while the quarter before that showed 1.80 B EUR of net income which accounts for −26.77% change. Track more AstraZeneca PLC financial stats to get the full picture.
AstraZeneca PLC dividend yield was 2.15% in 2023, and payout ratio reached 73.66%. The year before the numbers were 2.13% and 138.71% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 16, 2024, the company has 89.90 K employees. See our rating of the largest employees — is AstraZeneca PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AstraZeneca PLC EBITDA is 14.96 B EUR, and current EBITDA margin is 31.31%. See more stats in AstraZeneca PLC financial statements.
Like other stocks, ZEG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AstraZeneca PLC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AstraZeneca PLC technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AstraZeneca PLC stock shows the sell signal. See more of AstraZeneca PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.